Collins Eva, a trader with FundedNext, has been actively trading for over three years, focusing on both Forex and synthetic indices.
Collins Eva, a trader with FundedNext, has been actively trading for over three years, focusing on both Forex and synthetic indices.
Here are the Highlights of the article “Collins Eva: A Nigerian Trader’s Journey with FundedNext”:
Collins Eva, a seasoned trader with FundedNext, has been actively trading for over three years, focusing on both Forex and synthetic indices. His trading journey has led him to FundedNext, where he is currently in evaluation for a funded account.
Collins shared his approach to trading, emphasizing a simple yet effective strategy based on market structure. “I focus on buying low and selling high,” Collins explains. “I look for higher highs and higher lows in the market. Once I spot a bullish trend, I follow the momentum, aiming for the next higher high.” This approach has served him well across multiple currency pairs, with a preference for trading gold in particular.
However, Collins’ journey hasn’t been without challenges. He recently faced a setback in his evaluation account, hitting the daily drawdown limit during a news-driven market move. Despite this, he remains optimistic, using the experience as a learning opportunity. “It was due to news events that moved the market beyond my risk tolerance, but I’m working on improving my strategy and risk management,” he notes.
When asked about his experience with FundedNext, Collins highlights several features that stand out, including the platform’s fast 24-hour payout system and trader-friendly rules. “FundedNext makes it easier for traders, especially with their 15% profit share in the challenge phase and a more flexible news trading policy compared to other firms.”
For Collins, FundedNext has proven to be a great fit for his trading style and goals. “I was recommended FundedNext by a friend, and after seeing the benefits, especially in the challenge phase, I decided to join,” he says.
Here is the FundedNext Review.